Skip to search formSkip to main contentSkip to account menu

DP 432

Known as: DP-432, beta-alanyl-L-arginylglycyl-L-phenylalanyl-L-phenylalanyl-L-tyrosinamide, diacetate (salt) 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

InsulinPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Effects of modified insulin B21-B26 fragments on glycogenesis and on insulin-receptor complex fate in cultured fetal hepatocytes
1978
1978
Effects of Hexapeptide, a Compound Analogous to Insulin B Chain Fragment B-21-26(DP-432) on the Glucose Uptake into the Perfused Hind Limb of Rats
DP-432 is a synthetic new peptide analogous to insulin B-chain fragment B21-26. It has been reported that this hexapeptide shows… 
1977
1977
Insulin-like activities and insulin-potentiating actions of a modified insulin B21-26 fragment: beta-Ala-Arg-Gly-Phe-Phe-Tyr-NH2.
A modified sequence of insulin B21-26, beta-Ala-Arg-Gly-Phe-Phe-Tyr-NH2 (DP-432), was synthesized and tested for its biological… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)